Treatment patterns, effectiveness, and patient‐reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real‐world study-Reference-Cited by-全球学者库

Treatment patterns, effectiveness, and patient‐reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real‐world study

Published:2022-04-25 Issue:22 Volume:11 Page:4157-4168
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Shen Lesang¹²,Zhou Jun³,Chen Yiding¹^ORCID,Ding Jinhua⁴,Wei Haiyan⁵,Liu Jian³,Xia Wenjie⁶,Xie Bojian⁷,Xie Xiaohong⁸,Li Xujun⁹,Dai Yuechu¹⁰,Zhang Guobing¹¹,Qiu Xia¹²,Li Chao⁹,Sun Shanshan¹²,Chen Wuzhen¹²^ORCID,Gong Dihe¹³,Li Hengyu¹⁴,Huang Jian¹²,Jiang Xia¹⁵¹⁶,Ni Chao¹²

Affiliation:

1. Department of Breast Surgery Second Affiliated Hospital of Zhejiang University Hangzhou China

2. Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province Hangzhou China

3. Department of Breast Surgery Affiliated Hangzhou First People's Hospital of Zhejiang University Hangzhou China

4. Department of Breast Surgery Ningbo Medical Center Lihuili Hospital Ningbo China

5. Department of Breast Surgery First Affiliated Hospital of Zhejiang University Hangzhou China

6. Department of Breast Surgery Zhejiang Provincial People's Hospital Hangzhou China

7. Department of Breast Surgery Taizhou Enze Medical Center Enze Hospital Taizhou China

8. Department of Breast Surgery First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou China

9. Department of Breast Surgery Hwa Mei Hospital University of Chinese Academy of Sciences Ningbo China

10. Department of Breast Surgery Taizhou Municipal Hospital Taizhou

11. Quality Management Office Zhejiang Provincial People's Hospital Hangzhou China

12. Department of Breast Surgery Zhoushan Hospital of Zhejiang University Zhoushan China

13. Department of Breast Surgery Ningbo Hangzhou Bay Hospital Ningbo China

14. Department of General Surgery Affiliated Changhai Hospital of The Second Military Medical University Shanghai China

15. Department of Nutrition West China School of Public Health and West China Fourth Hospital, Sichuan University Chengdu China

16. Department of Clinical Neuroscience, Centre for Molecular Medicine Karolinska Institute Stockholm Sweden

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4767

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

3. Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

4. Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

5. Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review;Targeted Oncology;2023-04-19

2. Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population;Technology in Cancer Research & Treatment;2022-01